publications-2011-2013
CD49d expression as a promising biomarker to monitor natalizumab efficacy
Published on 19 March 2015
CD49d expression as a promising biomarker to monitor natalizumab efficacy
| Authors | Defer G, Mariotte D, Derache N, Toutirais O, Legros H, Cauquelin B, Le Mauff B |
| Journal | |
| Year | 2012 |
| Institute | I2BM |
Go back to list
Top page